Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Edwards Lifesciences Reports Second Quarter Results
July 27, 2017 8:30 AM EDT
Stifel raised its price target on Edwards Lifesciences (NYSE: EW) to $130.00 (from $118.00) while maintaining a Buy rating. For 3Q17, the company anticipates revenue between $810M-$850M with EPS at $0.80-$0.90 (mid-point: $0.85).
For 2017, Edwards now expects full-year revenue at the higher end of the $3.2 billion... More
July 27, 2017 7:33 AM EDT
Jefferies raised its price target on Edwards Lifesciences (NYSE: EW) to $132.00 (from $115.00) while maintaining a Buy rating following the company's 2Q. EW put up another impressive TAVR Q with +23.3% underlying y/y growth and +7% growth sequentially. After adding back $22.5mn of German inventory... More
July 26, 2017 4:19 PM EDT
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.08, $0.20 better than the analyst estimate of $0.88. Revenue for the quarter came in at $842 million versus the consensus estimate of $840.06 million.
GUIDANCE:
Edwards Lifesciences sees FY2017 EPS of $3.65-$3.85, versus the consensus of... More
